Advertisement

Topics

Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy

09:13 EDT 2 Aug 2017 | Labiotech.eu

TC Biopharm has just received the largest award of its kind to develop allogeneic gamma-delta T cell therapies for various cancers. Based in Glasgow, TC Biopharm was just selected to receive €4M from Horizon 2020 for its “off-the-shelf” gamma-delta T cell program. ...

This awesome article Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy

NEXT ARTICLE

More From BioPortfolio on "Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy"

Quick Search
Advertisement